ACXP stock

Acurx Pharmaceuticals LLC (ACXP) financials · $11.3M cap

Acurx Pharmaceuticals LLC (ACXP) $11.3M cap.

Cached annual income statement
LineFY2025FY2024
Revenue$0$0
Cost of Revenue$0$0
Gross Profit$0$0
Operating Income-$8.1M-$14.1M
Net Income-$8.0M-$14.1M
EPS (Diluted)$-5.32$-0.87
Cached annual balance sheet
LineFY2025FY2024FY2023
Total Assets$7.7M$3.9M$7.7M
Current Assets$0$3.9M$0
Cash & Equivalents$7.6M$3.7M$7.5M
Inventory$0$0$0
PP&E$0$0$0
Total Liabilities$2.4M$3.2M$3.0M
Current Liabilities$2.4M$3.2M$0
Short-term Debt$0$0$0
Long-term Debt$0$0$0
Total Debt$0$0$0
Shareholders' Equity$5.3M$615.1K$0
Retained Earnings-$75.3M-$67.3M$0
Cached annual cash flow
LineFY2025FY2024
Operating Cash Flow-$6.8M-$10.4M
CapEx$0$0
Investing Cash Flow$0$0
Financing Cash Flow$10.6M$6.6M
Dividends Paid$0$0
Net Change in Cash$3.8M$0
Free Cash Flow$0$0

FAQ

What is ACXP P/E and revenue?

Acurx Pharmaceuticals LLC (ACXP) $11.3M cap.

What is ACXP revenue?

Acurx Pharmaceuticals LLC last cached revenue is $0 (FY2025).

Is ACXP profitable?

Acurx Pharmaceuticals LLC last cached net income is -$8.0M.

What are ACXP total assets?

Acurx Pharmaceuticals LLC last cached total assets are $7.7M.

What is ACXP free cash flow?

Acurx Pharmaceuticals LLC last cached free cash flow is $0.

Not investment advice. Cached statements, not a live tape.